Sg Americas Securities, LLC Seer, Inc. Transaction History

Sg Americas Securities, LLC

$20.8 Billion
Q1 2024

A detailed history of Sg Americas Securities, LLC transactions in Seer, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 20,224 shares of SEER stock, worth $33,976. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,224

Previous 30,915 34.58%

Holding current value

$33,976

Previous $60,000 36.67%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$1.54 - $2.09 $16,464 - $22,344	-10,691 Reduced 34.58%	20,224 $38,000
Q4 2023 Jan 12, 2024	BUY	$1.47 - $2.22 $8,017 - $12,107	5,454 Added 21.42%	30,915 $60,000
Q3 2023 Oct 13, 2023	BUY	$2.18 - $5.52 $55,504 - $140,544	25,461 New	25,461 $56,000
Q1 2023 Apr 28, 2023	BUY	$3.6 - $5.88 $31,539 - $51,514	8,761 Added 46.15%	27,744 $107,000
Q4 2022 Feb 02, 2023	BUY	$5.03 - $8.58 $2,645 - $4,513	526 Added 2.85%	18,983 $110,000

Q3 2022 Oct 31, 2022	SELL	$7.7 - $13.31 $17,086 - $29,534	-2,219 Reduced 10.73%	18,457 $143,000
Q2 2022 Jul 29, 2022	BUY	$6.72 - $16.07 $138,942 - $332,263	20,676 New	20,676 $185,000
Q1 2022 Apr 29, 2022	SELL	$11.88 - $23.4 $139,328 - $274,435	-11,728 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$21.08 - $38.51 $208,481 - $380,863	-9,890 Reduced 45.75%	11,728 $268,000
Q3 2021 Nov 01, 2021	BUY	$27.67 - $45.04 $598,170 - $973,674	21,618 New	21,618 $746,000
Q2 2021 Aug 12, 2021	SELL	$28.75 - $56.92 $58,333 - $115,490	-2,029 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$38.67 - $84.06 $319,839 - $695,260	-8,271 Reduced 80.3%	2,029 $101,000
Q4 2020 Feb 04, 2021	BUY	$55.23 - $81.11 $568,869 - $835,433	10,300 New	10,300 $578,000

Others Institutions Holding SEER

# of Institutions

Shares Held

42.9M

Call Options Held

200

Put Options Held

View Full List

About Seer, Inc.

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $98.4M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

More about SEER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Seer, Inc. Transaction History